Healthcare & Life Sciences
Ventus Therapeutics
United Stateswww.ventustx.com/
Ventus Therapeutics is a series c plus startup based in United States. 1 investor tracked.
Activeseries-c-plus
series-c-plus
Stage
2019
Founded
2
Investors
About Ventus Therapeutics
Based in the United States, Ventus Therapeutics is a startup founded in 2019. Its most recent tracked round is Series C+. Brouky classifies it under Healthcare & Life Sciences. Brouky records 2 investors associated with the company.
Ventus Therapeutics is a clinical-stage biopharmaceutical company that uses structure-based drug discovery to develop small-molecule medicines. Its lead programs include VENT-03, a cGAS inhibitor in Phase 2 for lupus, and VENT-02, a brain-penetrant NLRP3 inhibitor in Phase 2 for Parkinson’s disease.
Explore Ventus Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.